Literature DB >> 10228003

CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.

S F Greer1, L B Justement.   

Abstract

Cross-linking of CD45 induced capping and physical sequestration from CD22 leading to an increase in tyrosine phosphorylation of CD22 and SHP-1 recruitment. Additionally, CD22 isolated from a CD45-deficient B cell line exhibited increased basal/inducible tyrosine phosphorylation and enhanced recruitment of SHP-1 compared with CD22 isolated from CD45-positive parental cells. Subsequent experiments were performed to determine whether enhanced SHP-1 recruitment to CD22 is responsible for attenuation of receptor-mediated Ca2+ responses in CD45-deficient cells. Catalytically inactive SHP-1 expressed in CD45-deficient cells interacted with CD22 and decreased phosphatase activity in CD22 immunoprecipitates to levels that were comparable to those in CD45-positive cells. Expression of catalytically inactive SHP-1 restored intracellular mobilization of Ca2+ in response to MHC class II cross-linking, but did not affect B cell Ag receptor- or class II-mediated Ca2+ influx from the extracellular space. These results indicate that CD45 regulates tyrosine phosphorylation of CD22 and binding of SHP-1. The data further indicate that enhanced recruitment and activation of SHP-1 in CD45-deficient cells affect intracellular mobilization of Ca2+, but are not responsible for abrogation of receptor-mediated Ca2+ influx from the extracellular space.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228003

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray.

Authors:  S Li; D T Ross; M E Kadin; P O Brown; M A Wasik
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

Review 3.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

4.  Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.

Authors:  Roland B Walter; Kelli M Boyle; Frederick R Appelbaum; Irwin D Bernstein; John M Pagel
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

Review 5.  Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity.

Authors:  Taher E Taher; Jonas Bystrom; Voon H Ong; David A Isenberg; Yves Renaudineau; David J Abraham; Rizgar A Mageed
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

6.  Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans.

Authors:  N Giovannone; J Liang; A Antonopoulos; J Geddes Sweeney; S L King; S M Pochebit; N Bhattacharyya; G S Lee; A Dell; H R Widlund; S M Haslam; C J Dimitroff
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

7.  Inducing secondary metabolite production of Aspergillus sydowii through microbial co-culture with Bacillus subtilis.

Authors:  Yu Sun; Wen-Cai Liu; Xuan Shi; Hai-Zhou Zheng; Zhi-Hui Zheng; Xin-Hua Lu; Yan Xing; Kai Ji; Mei Liu; Yue-Sheng Dong
Journal:  Microb Cell Fact       Date:  2021-02-12       Impact factor: 5.328

8.  Molecular basis of human CD22 function and therapeutic targeting.

Authors:  June Ereño-Orbea; Taylor Sicard; Hong Cui; Mohammad T Mazhab-Jafari; Samir Benlekbir; Alba Guarné; John L Rubinstein; Jean-Philippe Julien
Journal:  Nat Commun       Date:  2017-10-02       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.